Verona Pharma PLC Holding(s) in Company (5192E)
May 08 2017 - 11:33AM
UK Regulatory
TIDMVRP
RNS Number : 5192E
Verona Pharma PLC
08 May 2017
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES(i)
------------------------------------------------------------------------------------------
1. Identity of the issuer or Verona Pharma plc
the underlying issuer
of existing shares to which
voting rights are
attached:
-------------------------------------------------------- --------------------------------
2 Reason for the notification (please tick the appropriate
box or boxes):
------------------------------------------------------------------------------------------
An acquisition or disposal of voting rights ΓΌ
------------------------------------------------------------ ----------------------------
An acquisition or disposal of qualifying financial
instruments which may result in the acquisition
of shares already issued to which voting rights
are attached
------------------------------------------------------------ ----------------------------
An acquisition or disposal of instruments with
similar economic effect to qualifying financial
instruments
------------------------------------------------------------ ----------------------------
An event changing the breakdown of voting rights
------------------------------------------------------------ ----------------------------
Other (please specify):
---------------------------------------------------- ------ ----------------------------
3. Full name of person(s) Growth Equity Opportunities
subject to the IV, LLC
notification obligation:
------------------------------------------------------ ----------------------------------
4. Full name of shareholder(s)
(if different from 3.):
------------------------------------------------------ ----------------------------------
5. Date of the transaction May 2, 2017
and date on
which the threshold is
crossed or
reached:
------------------------------------------------------ ----------------------------------
6. Date on which issuer May 5, 2017
notified:
------------------------------------------------------ ----------------------------------
7. Threshold(s) that is/are 8% to 9% change at direct
crossed or interest level
reached:
------------------------------------------------------ ----------------------------------
8. Notified details:
----------------------------------------------------------------------------------------------------------------------
A: Voting rights attached to shares
----------------------------------------------------------------------------------------------------------------------
Class/type Situation previous Resulting situation after the
of to the triggering triggering transaction
shares transaction
if possible
using
the ISIN
CODE
------------- -------------------------------- ---------------------------------------------------------------------
Number Number Number Number of % of voting
of of of shares voting rights
Shares Voting rights
Rights
------------- --------------- --------------- -------------- -------------------------- -------------------------
Direct Direct Indirect Direct Indirect
------------- ----------- ----------- -------------- ------------ ------------ ------------ -----------
Ordinary
Shares
GB00B06GSH43 4,424,065 4,424,065 4,424,065 4,424,065 4.47%
--------------- --------------- -------------- ------------ ------------ ------------ -----------
US9250501064 5,333,328 5,333,328 5.39%
------------- --------------- --------------- -------------- ------------ ------------ ------------ -----------
B: Qualifying Financial Instruments
----------------------------------------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
----------------------------------------------------------------------------------------------------------------------
Type of Expiration Exercise/ Number of voting % of voting
financial date Conversion rights that rights
instrument Period may be
acquired if
the
instrument
is
exercised/
converted.
----------------- ------------- ------------------------------- ---------------------------- ---------------------
C: Financial Instruments with similar economic effect
to Qualifying Financial Instrument
----------------------------------------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
----------------------------------------------------------------------------------------------------------------------
Type of Exercise Expiration Exercise/ Number of voting % of voting
financial price date Conversion rights instrument rights
instrument period refers to
--------------- ------------- ------------- ---------------- ---------------------------- -----------------------
Nominal Delta
--------------- ------------- ------------- ---------------- ---------------------------- ------------ ---------
Total (A+B+C)
----------------------------------------------------------------------------------------------------------------------
Number of voting rights Percentage of voting rights
------------------------------------------------- -------------------------------------------------------------------
9,757,393 9.86%
------------------------------------------------- -------------------------------------------------------------------
9. Chain of controlled undertakings through which the
voting rights and/or the
financial instruments are effectively held, if applicable:
-----------------------------------------------------------------------------------------------
Growth Equity Opportunities IV, LLC is a limited liability
company formed in the State of Delaware, United States
New Enterprise Associates 15, L.P., a limited partnership
formed in the State of Delaware, is its sole member
NEA Partners 15, L.P., a limited partnership formed
in the State of Delaware, is its general partner
NEA 15 GP, LLC, a limited liability company formed in
the State of Delaware, is its general partner
Proxy Voting:
-----------------------------------------------------------------------------------------------
10. Name of the proxy holder:
-------------------------------------------------------------- -------------------------------
11. Number of voting rights proxy
holder will cease
to hold:
-------------------------------------------------------------- -------------------------------
12. Date on which proxy holder will
cease to hold
voting rights:
-------------------------------------------------------------- -------------------------------
13. Additional information: Figures are based on a total
number of 99,014,164 Ordinary
Shares outstanding, as per
the Company's Announcement
of May 2, 2017.
-------------------------------------------------------------- -------------------------------
14. Contact name: Louis Citron, New Enterprise
Associates
-------------------------------------------------------------- -------------------------------
15. Contact telephone number: +1 (410) 842-4000
-------------------------------------------------------------- -------------------------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLUGUBPAUPMGQR
(END) Dow Jones Newswires
May 08, 2017 12:33 ET (16:33 GMT)
Verona Pharma (LSE:VRP)
Historical Stock Chart
From Apr 2024 to May 2024
Verona Pharma (LSE:VRP)
Historical Stock Chart
From May 2023 to May 2024
Real-Time news about Verona Pharma Plc (London Stock Exchange): 0 recent articles
More Verona Pharma News Articles